I agree, but while the monthly prescriptions or sales information is price sensitive once released, I don’t think these are compulsory. We have just become used to them! So they can wait and release whatever they want as long as they satisfy the normal reporting guidelines.
That’s my understanding, anyway. Correct me if I’m wrong.
- Forums
- ASX - By Stock
- BOD
- Bod Pharmaceuticals & collaborations
Bod Pharmaceuticals & collaborations, page-11
Featured News
Add BOD (ASX) to my watchlist
|
|||||
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.256M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
BOD (ASX) Chart |
Day chart unavailable